$8.56
Today
as of Oct 2, 16:45 ET
Last 30 days
Recent Press Releases & News
Agomab stock jumps on positive trial data
Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
AGMB earnings at a glance
The share price of $8.56 sits near its 52-week low.
Overview
52-week range
$8.00
$18
6% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for AGMB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.